Speed of Processing Training to Improve Cognitive Functioning and Driving Performance in Head and Neck Cancer Survivors

Starting soon · Not applicable · Has a placebo group

Conditions studied: Head and Neck Cancer (H&N)

In brief

The goal of the study is to understand how well cognitive training improves reaction time in people with head and neck cancer (HNC). Aim 1. Evaluate the preliminary clinical effectiveness of a 10-week home- and video game-based SOPT on cognitive functioning and driving performance in HNC survivors. This study will include completing five questionnaires and simulated driving in a simulator at two different times, 10 weeks of participating in 2 sessions per week of video-game cognitive training at home and being interviewed once at the end of the 10-week training.

Key facts

Study ID

NCT07740616

Run by

University of Alabama at Birmingham

People needed

30

Starts

2026-09-03

Expected to finish

2029-09-01

Last updated by the study team

2026-07-31

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• confirmed HNC diagnosis
• aged ≥ 18 years of all racial, ethnic, and sex/gender categories
• ≥ 6 months post radiation or chemoradiation
• self-reported CRCI, defined as a score of ≥ 60 in the FACT-Cog Perceived Cognitive Impairment subscale
• thyroid-stimulating hormone levels within normal limits
• visual acuity of at least 20/40 using a Snellen eye chart
• functional peripheral vision as indicated by the confrontation field test
• functional hearing sufficient to engage in daily conversation in English for ≥ 15 minutes
• intact lower extremity function (Rapid Pace Walk test ≤ 9 sec)
• stable home internet
• sufficient English proficiency to read and understand informed consent materials

You may not qualify if…

• significant neurologic or psychiatric comorbidities, including psychotic disorders, bipolar disorders, Alzheimer's disease or related dementias, developmental disorders, seizure disorders, vestibular disorders, prior brain tumor or brain surgery, or poorly controlled metabolic disease
• current use of antipsychotic or mood-stabilizing medications due to potential effects on driving performance
• anticipated life expectancy of < 6 months based on physician prognosis.

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.